If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksProvexis Regulatory News (PXS)

Share Price Information for Provexis (PXS)

Share Price is delayed by 15 minutes
Get Live Data
1.28    -0.03 (-2.33%)
Bid:
1.23
Ask:
1.29
Spread: 0.06 (4.878%)
Market Cap: £30.03m
PXS Live PriceLast checked at - London Stock Exchange

Intraday Provexis Share Chart

Directorate Change

4 May 2007 14:35

Provexis PLC04 May 2007 4 May 2007 PROVEXIS PLC ("Provexis" or the "Company") Directorate Change Provexis plc (ticker PXS.L), the nutraceutical company that developsscientifically-proven functional and medical foods, has appointed Jonathan BrettDiggines to its Board as a non-executive director with immediate effect. Jonathan Diggines, 54, is Chief Executive Officer of Enterprise Ventures GroupLimited, a 19.4 per cent shareholder in the Company. Jonathan, who is asolicitor, joined Enterprise Ventures in 2005 and had previously spent 10 yearsas Managing Director of Murray Johnstone Private Equity where he managedsubstantial private equity and venture funds. Jonathan holds or has held thefollowing directorships or been a partner in the following partnerships withinthe five years prior to this announcement: • Enterprise Ventures (General Partner Coalfields) Limited • Enterprise Ventures (General Partner EVF/LEV) Limited • Enterprise Ventures (General Partner HSBC European Fund) Limited • Enterprise Ventures (General Partner HSBC UK Enterprise Fund) Limited • Enterprise Ventures (General Partner Rising Stars) Limited • Enterprise Ventures (General Partner Rising Stars II) Limited • Enterprise Ventures Limited • Enterprise Ventures Group Limited • Enterprise Ventures Nominees Limited • LE Founders Limited • LE Founders II Limited • LE Founders III Limited • Nichols plc • North West Enterprise Investment Limited • Rising Stars Growth Fund Limited • Carbutt & Co. (1928) Limited • LE Founders Limited • MJPAP (Syndications) Limited • MJPAP II (Syndications) Limited • T F Willow Limited • Weigh A Way Limited • W F P Willow Limited • W G Willow Limited • W I Willow Limited • W Willow Limited • British Venture Capital Association • RAL (S&G) Limited • Sumit Venture Fund One Limited • STF Management Limited • SEV Investments Limited • SEV Holdings Limited • BIG (General Partner) Limited • Regent Street Ventures Limited • Aberdeen Murray Johnstone Private Equity Limited • Euractions Management Limited • Murray Johnstone Limited • Callform Limited • Aberdeen Growth Opportunities VCT PLC • M J Founders Limited • COIP (GB) Limited • Aberdeen Asset Managers Limited • AMJPEF Founder Partner Limited • AMJPEF GP Limited There are no further disclosures to be made in accordance with Schedule 2(g) ofthe AIM Rules. Dawson Buck, Chairman of Provexis said: "I am delighted that Jonathan Diggineshas joined the Board of Provexis. He brings a considerable wealth of experiencegained from his management of venture funds and from his portfolio ofnon-executive director roles both in public and private companies, including anumber of significant food and drink sector investments. These attributescombined with his standing in the private equity and venture capital industrywill add significant value to the strategic development of our proprietarytechnologies." - ENDS - Enquiries: Provexis PlcStephen Moon, Chief Executive Officer 020 8392 6634 Arbuthnot SecuritiesTom GriffithsAlasdair Younie 020 7012 2000 Adventis Financial PRChris Steele 020 7034 4759Annie Evangeli 020 7034 4757 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Jul 20127:00 amRNSFinal Results
27th Jul 20127:00 amRNSNotice of Results
31st May 20127:00 amRNSTotal Voting Rights
17th May 20127:00 amRNSDraw Down of Funds and Issue of Equity
24th Apr 20127:00 amRNSScience in Sport brand relaunch
23rd Apr 20124:31 pmRNSAdditional Listing
2nd Apr 20127:00 amRNSDirectorate Change
30th Mar 201211:46 amRNSTotal Voting Rights Update
30th Mar 20127:00 amRNSPre-Close Update
16th Mar 20124:35 pmRNSPrice Monitoring Extension
12th Mar 20124:40 pmRNSSecond Price Monitoring Extn
12th Mar 20124:35 pmRNSPrice Monitoring Extension
12th Mar 20127:00 amRNSScience in Sport Update
14th Feb 20127:00 amRNSFruitflow update
9th Jan 20124:40 pmRNSSecond Price Monitoring Extn
9th Jan 20124:35 pmRNSPrice Monitoring Extension
9th Jan 20127:00 amRNSProvexis to fuel GB rowing team
7th Dec 20113:01 pmRNSAdditional Listing
1st Dec 20117:00 amRNSChange of adviser
1st Dec 20117:00 amRNSInterim Results
28th Nov 20117:00 amRNSNotice of Interim Results
8th Nov 20117:00 amRNSRenewal of £25 million Equity Financing Facility
24th Aug 20113:24 pmRNSResult of AGM
24th Aug 20117:00 amRNSAGM Statement
8th Aug 20114:40 pmRNSSecond Price Monitoring Extn
8th Aug 20114:35 pmRNSPrice Monitoring Extension
4th Aug 20114:40 pmRNSSecond Price Monitoring Extn
4th Aug 20114:35 pmRNSPrice Monitoring Extension
1st Aug 20115:22 pmRNSNotice of AGM
29th Jul 20117:00 amRNSTotal Voting Rights
26th Jul 20114:46 pmRNSResult of open offer
15th Jul 20114:35 pmRNSHolding(s) in Company
14th Jul 201110:44 amRNSHolding(s) in Company
12th Jul 20114:23 pmRNSHolding(s) in Company
12th Jul 20119:17 amRNSHolding(s) in Company
11th Jul 20111:42 pmRNSChange of Registered Office
5th Jul 20117:00 amRNSOpen Offer
30th Jun 20114:55 pmRNSHolding(s) in Company
30th Jun 20117:00 amRNSTotal Voting Rights
28th Jun 20113:34 pmRNSHolding(s) in Company
24th Jun 201112:08 pmRNSCompletion of the acquisition of SiS
20th Jun 20119:36 amRNSDirector Dealing
17th Jun 20114:15 pmRNSGrant of Options
17th Jun 20117:00 amRNSFinal Results
17th Jun 20117:00 amRNSAcquisition of Science in Sport Ltd
1st Jun 20117:00 amRNSUpdate on Crohn's disease trial
1st Jun 20117:00 amRNSAppointment of New Product Director
1st Jun 20117:00 amRNSSigning of Development Agreement
31st Mar 20117:00 amRNSPre-close update
28th Feb 20118:49 amRNSDevelopment Agreement - Replacement announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.